Mineralys Therapeutics Inc. – Filings and Transcripts

NASDAQ: MLYS
Share price (5/22/26): $29.85
Market cap (5/22/26): $2.463 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Automatic shelf registration

Prospectus supplement for primary offering

Addition of securities to prior shelf registration

Prospectus supplement for primary offering

Ownership Filter

Rodman David Malcom

Rodman David Malcom

Rodman David Malcom

Rodman David Malcom

Rodman David Malcom

News Filter

Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update

Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults With Hypertension and Topline Explore-Osa Trial Results

Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Correspondence with the SEC